Conclusion: This study concluded that quantitative washout calculated on Triphasic CT scan is a highly sensitive and accurate non-invasive modality for diagnosis of hepatocellular carcinoma
Study 304 is a multicenter, randomized, open-label, global Phase III study comparing the efficacy and safety of lenvatinib versus sorafenib, a standard treatment for advanced hepatocellular carcinoma
, as a first-line treatment for patients with unresectable hepatocellular carcinoma
Signal transducer and activator of transcription 3 showed a high level in hepatocellular carcinoma
Keywords: Hepatocellular carcinoma
, computed tomography, radiofrequency ablation, Sonazoid, C[O.
There were few effective therapeutic options available for those suffering from advanced disease7 but progress has been seen in surgical treatment of hepatocellular carcinoma
1 Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma
has different signs and symptoms, depending on the size of the tumor, invasion of vascular structures, presence of cirrhosis and presensce of metastases.
The report provides a snapshot of the global therapeutic landscape of Hepatocellular Carcinoma
The risk factors associated with hepatocellular carcinoma
are Hepatitis B virus (HBV) infection and hepatitis C virus (HCV) infection, alcoholic cirrhosis, metabolic syndrome, biliary cirrhosis, and chronic liver injury.
confirmed the existence of typical DNA CNVs in the peripheral blood of 4 hepatocellular carcinoma
patients by using massively parallel sequencing, and they almost all disappeared after surgical treatment .
Patients with liver mass on ultrasound and CT scan with raised alpha feto protein were labeled hepatocellular carcinoma
were divided in the Child Class A, B or C.
The report reviews key players involved in the therapeutics development for Hepatocellular Carcinoma
and enlists all their major and minor projects